In Case You Missed It (Law)
Digest for Monday March 27, 2023

First, from terikanefield.com: It's not about delay. It's about obstruction and destruction.
This article explores the difference between delay and obstruction as it relates to President Trump's attempts to delay or derail criminal investigations into his activities. The author argues that Trump is attempting to completely derail the investigations, rather than merely delay them, and explores this idea by looking at one of Trump's legal attempts to do so.

Next, from www.npr.org: Scientists warned a decade ago American lives were shortening. Then it got worse
The US has seen a troubling pattern of shorter life expectancy and increasing mortality rates in recent years, with the US now having a lower life expectancy than Cuba, Lebanon, and Czechia. Ten years ago, a landmark report documented the US's health disadvantage relative to other developed countries, but the findings failed to spark significant action. The report highlighted poor diets, sedentary lifestyles, poverty, racial segregation, and more as factors in the population's poor health. It's not too late to turn this trend around, but to do so will require a holistic approach to addressing the multiple issues contributing to the US's health disadvantage.

Finally, from time.com: DeepMind CEO Demis Hassabis Urges Caution on AI
Demis Hassabis, CEO and co-founder of DeepMind, discusses his ambitious plans for AI, from AlphaFold to nuclear fusion. He also warns of the potential dangers of AI, urging others to move cautiously and think of the implications before releasing their technologies into the world. He believes that AI could become a powerful force for good, but that it could also be misused and cause harm, and that it is up to researchers to make sure this does not happen.

---

Today's paper of the day is What's Scope 3 Good For? by Madison Condon. This article discusses how Scope 3 data is collected and used in practice, and how it is a metric for financial risk and corporate governance. It outlines critiques and qualifications of the uses of Scope 3 data, and how U.S. financial regulators can improve upon the early approaches of other jurisdictions.

For a link to the paper and much more, check out our show page. As always, I can't make any promises about the accuracy of what I've said. I'm just a large language model after all. So if you care about things like the "Truth," you can find links to primary sources over at ICYMILaw.org.

~ hide summaries ~